Concepedia

Author

Sarah Brand

Ithaka HarborsORCID

Also Known As

Brand, Sarah, Joanne Howard, Juliana Bordignon Draibe, S. Brand, SARAH BRAND, Sarah B Brand, Sarah B. Brand, Sarah Brand

26

Publications

357

Citations

11

H-Index

14

Concepts

All Affiliations

Ithaka HarborsBoehringer Ingelheim (United States)Boehringer Ingelheim (Germany)Boehringer Ingelheim (Brazil)Heidelberg University
SB

About

Sarah Brand is an author at Ithaka Harbors specializing in renal disease, diabetes, and cardiovascular disease.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Health Sciences

1

1

45

2

Medicine

1

1

45

3

Diabetes

1

1

45

4

Health Policy

1

1

45

5

Nephrology

1

1

45

Sarah Brand

×

9

Publications

283

Citations

9

H-Index

YearCitations

Cost-effectiveness and public health benefit of secondary cardiovascular disease prevention from improved adherence using a polypill in the UK

Virginia Becerra, Alfredo Gracia, Kamal Desai,

BMJ Open

2015

89

Cost-Effectiveness of Empagliflozin in Patients With Diabetic Kidney Disease in the United States: Findings Based on the EMPA-REG OUTCOME Trial

Odette S. Reifsnider, Christoph Wanner, Egon Pfarr,

American Journal of Kidney Diseases

2021

45

Cost-Effectiveness of Empagliflozin in the UK in an EMPA-REG OUTCOME Subgroup with Type 2 Diabetes and Heart Failure

Odette S. Reifsnider, Jennifer Franke, Joseph H. Lee,

ESC Heart Failure

2020

29

Cost‐effectiveness analysis of empagliflozin versus sitagliptin as <scp>second‐line</scp> therapy for treatment in patients with type 2 diabetes in the United States

Odette S. Reifsnider, Pratik Pimple, Valerie Aponte Ribero,

Diabetes Obesity and Metabolism

2020

24

Cost-effectiveness of empagliflozin versus canagliflozin, dapagliflozin, or standard of care in patients with type 2 diabetes and established cardiovascular disease

Odette S. Reifsnider, Pranav Gandhi, Lael Cragin,

BMJ Open Diabetes Research & Care

2021

24

Quality of Life and its Determinants in Patients With Adrenal Insufficiency: A Survey Study at 3 Centers in the United States

Dingfeng Li, Sarah Brand, Oksana Hamidi,

The Journal of Clinical Endocrinology & Metabolism

2022

24

Efficacy and Cost-Effectiveness of Dabigatran Etexilate Versus Warfarin in Atrial Fibrillation in Different Age Subgroups

Andreas Clemens, Siyang Peng, Sarah Brand,

The American Journal of Cardiology

2014

23

Economic evaluation of betibeglogene autotemcel (Beti-cel) gene addition therapy in transfusion-dependent β-thalassemia

Odette S. Reifsnider, Sarah Brand, Neil Hawkins,

Journal of Market Access & Health Policy

2021

14

<scp>Cost‐effectiveness</scp> of <scp>second‐line</scp> empagliflozin versus liraglutide for type 2 diabetes in the United States

Odette S. Reifsnider, Pratik Pimple, Sarah Brand,

Diabetes Obesity and Metabolism

2021

11

Page 1